Tech Company Financing Transactions

Celsius Therapeutics Funding Round

Casdin Capital, Alexandria Venture Investments and Amgen Ventures participated in a Series B funding round for Celsius Therapeutics. The funding round was announced by the company on 3/24/2022 10:31:59 PM.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

399 Binney St.
Cambridge, MA 02139
USA

Phone

857-776-7400

Website

www.celsiustx.com

Email Address

[email protected]

Overview

Celsius Therapeutics is charting a new course of target and drug discovery by understanding the specific cells, among many others, that are key players in disease and by identifying the genes that are triggering their malfunction.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chairman

Alexis Borisy

        

Chief Executive Officer

Tariq Kassum

        

Chief Scientific Officer

Christoph Lengauer

        

VP - Bus. Development

Michael Boretti

        

VP - Human Resources

Andrea Armstrong

        

Browse more venture capital transactions:

Prev: 3/24/2022: Kwik by Africa Delivery Technologies venture capital transaction
Next: 3/24/2022: Outgo venture capital transaction

Share this article

Where The Data Comes From

Our team works diligently to document all VC transactions involving tech companies. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary